References
- Klein SS, Bloom J, Gnirke M, et al. Comment on: Are antimuscarinic effects common in hydroxyzine overdose? A cohort analysis of antimuscarinic effects in hydroxyzine and diphenhydramine poisoned patient. Clin Toxicol. 61:379–386.
- Simon M, Heard K. Are antimuscarinic effects common in hydroxyzine overdose? A cohort analysis of antimuscarinic effects in hydroxyzine and diphenhydramine-poisoned patients. Clin Toxicol. 2023;61(5):379–386. doi:10.1080/15563650.2023.2200575.
- Gummin D, Mowry J, Beuhler M, et al. Annual report of the national poison data system© (NPDS) from america’s poison centers: 39th annual report. Clin Toxicol. 2022;60(12):1381–1643. 2022; doi:10.1080/15563650.2022.2132768.
- U.S. Food and Drug Administration. Benadryl (diphenhydramine): Drug Safety Communication. 2020. https://www.fda.gov/safety/medical-product-safety-information/benadryl-diphenhydramine-drug-safety-communication-serious-problems-high-doses-allergy-medicine
- Berman B. Perennial allergic rhinitis: clinical efficacy of a new antihistamine. J Allergy Clin Immunol. 1990;86(6):1004–1008. doi:10.1016/S0091-6749(05)80244-1.
- Sicari V, Zabbo CP. Diphenhydramine. 2022 Jul 11. In: statPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023. Available at: https://www.statpearls.com/ArticleLibrary/viewarticle/20535